• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Katie Pfaff

Articles by Katie Pfaff

Roche wins FDA nod for Zika screening test

Oct. 9, 2017
By Katie Pfaff
Roche Molecular Systems Inc. was awarded FDA approval for its donor-screening blood test for the Zika virus. The cobas test, which can be run on cobas 6800 or 8800 systems, is the first of its kind for commercial screening.
Read More

Animas to leave U.S., Canadian insulin pump market, customers transitioning to Medtronic

Oct. 6, 2017
By Katie Pfaff
Animas Corp., a Johnson & Johnson diabetes care company will leave the insulin pump market in the U.S. and Canada, and discontinue its Animas, Vibe and Onetouch Ping insulin pumps. The company will manage a transition to alternate devices for its patients, working with chosen partner, Medtronic plc, in that effort.
Read More

Nexxt Spine wins FDA nod for Matrixx spinal system

Oct. 5, 2017
By Katie Pfaff

Enteromedics acquires Reshape Medical and obesity balloon system

Oct. 4, 2017
By Katie Pfaff

Panel says 3-D printing opens many possibilities in med-tech production

Oct. 2, 2017
By Katie Pfaff

Med tech looks more attractive to investors under evolving conditions

Sep. 29, 2017
By Katie Pfaff

Nelson says Medical device cybersecurity needs to be addressed by manufacturers

Sep. 28, 2017
By Katie Pfaff

Disruption and change on tap for med-tech industry, says panel on future of leadership

Sep. 28, 2017
By Katie Pfaff
SAN JOSE, Calif. – Panelists tackled data, innovation and changes organizations need to make to adapt to the upcoming trends in a session at the Advance Medical Technology Association's (AdvaMed) MedTech Conference. An all-female panel of speakers discussed what leadership should do to prepare for business movement toward big data and machine learning, consumer trends and valuing people in an organization at "The future of leadership in medtech: trends of disruption and consolidation" panel.
Read More

Artificial intelligence shows promise to enhance devices with careful oversight

Sep. 27, 2017
By Katie Pfaff

Panelists say big deals, investment continue in med-tech industry

Sep. 27, 2017
By Katie Pfaff
Previous 1 2 … 11 12 13 14 15 16 17 18 19 … 23 24 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 27, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 27, 2025.
  • Vertex divulges new Nav1.8 blockers for pain

    BioWorld Science
    Vertex Pharmaceuticals Inc. has synthesized sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers reported to be useful for the treatment of pain.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • Woman holding neck

    Merus combo trounces Keytruda in head-and-neck phase II

    BioWorld
    Investor hopes rose sharply for Merus NV’s phase III trials – data should roll out next year – with bispecific antibody petosemtamab after mid-stage results...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe